Alanine aminotransferase (ALT) is a routine parameter in the assessment and monitoring of chronic hepatitis C viral (HCV) infection. Hepatitis C virus-infected African Americans (AAs) have been reported to have lower ALT levels. In this retrospective, cross-sectional, multicenter study, host and virological factors possibly associated with ALT levels were analyzed by multivariate regression analyses among HIV/HCV-coinfected patients. Of the 289 patients included, 142 were African Americans and 144 Caucasians. In multivariate analysis, only HCV genotype 3 (B 0.2 [95% CI 13.39-52.33]; P ¼ .001) and HCV RNA >500 000 IU/mL (B 3.1 [95% CI 7.67-34.75]; P ¼ .002) were independent predictors of higher ALT levels. Per the American Association for the Study of Liver Disease (AASLD) definition, 18.2% had ALT levels within normal limits. Male sex and HCV RNA <500 000 IU/mL predicted ALT within normal limits. Hepatitis C viral factors rather than race were associated with ALT levels in this HIV/HCV-coinfected population. ALT were within normal limits in 18% of patients, who more often were male and had lower Hepatitis C viral load.
Introduction
In the era of highly active antiretroviral therapy (HAART), hepatitis C virus (HCV) has become an important comorbidity in the HIV-infected population. HIV-positive patients coinfected with HCV are more susceptible to accelerated liver fibrosis than their HCV-monoinfected counterparts. 1, 2 Efforts are being made to treat these patients to prevent the deleterious consequences of the infection.
In the assessment and monitoring of HCV chronic infection, alanine aminotransferase (ALT) levels represent an inexpensive and easy-to-obtain parameter. Although not perfect, it can provide some information on the liver histological activity. 3 Host and virological factors have been shown to affect ALT levels in patients with chronic HCV infection. Hepatitis C virus-infected African Americans have been reported to have lower ALT levels than white HCV-infected patients. [4] [5] [6] [7] In the United States, African Americans represent a majority of the HIV/HCV-coinfected population. 2, 8 Data on the factors that determine ALT levels in HIV/HCV-coinfected patients are scarce. The objectives of the current study were to determine whether-as it has been reported in HCV-monoinfected patients-racial factors are also related to transaminase levels in the HIV/HCV-coinfected population and to explore other host and viral factors that could correlate with ALT levels by analyzing a large and diverse group of HIV/HCV-coinfected patients.
positive anti-HCV antibody serology and detectable HCV RNA by polymerized chain reaction (PCR) with a concurrent ALT determination were included in the study. The reference upper limit of normal ALT used for males and females was 30 IU/L and 19 IU/L, respectively, based on the most recent American Association for the Study of Liver Disease (AASLD) recommendations. 9 Individuals with positive Hepatitus B surface antigen (HBsAg) were not included in the study. Participants who cleared HCV spontaneously or after treatment were excluded from the study.
Epidemiological data, including age, sex, race, geographical location, HCV genotype, HCV RNA, ALT, and aspartate aminotransferase (AST) levels, were recorded. Data on alcohol use, CD4 count, HIV viral load, and antiretroviral medication were not included.
All patients had a positive HIV antibody by enzyme-linked immunosorbent assay (ELISA) that was confirmed by Western blot, positive anti-HCV antibody by EIA or ELISA, and quantitative serum HCV RNA (determined by PCR, with diverse lower limits of detection ranging from 5 to 600 IU/mL depending on the center and time of assay). Laboratory analyses were performed at the local laboratories or as send-out tests to reference laboratories, depending on the standard of care at each institution.
Data were analyzed using descriptive statistical analysis: median and interquartile ranges for continuous variables and proportions for categorical variables. Primary outcomes of interest were ALT levels and percentage of patients with normal ALT. Comparisons between 2 groups were done using chi-square and Student t tests for categorical and continuous variables, respectively. Comparison of continuous variables between more than 2 groups was done using analysis of variance (ANOVA). Univariate and multivariate linear regression analyses were performed to analyze factors linked to ALT levels. Univariate and multivariate logistic regression analyses were performed to analyze factors associated with ALT levels within normal limits. Pearson's correlation was used to explore possible correlation between HCV RNA and ALT levels. Differences with P values < .05 were considered significant.
All analyses were performed using Statistical Package for the Social Sciences (SPSS; version 11.0, SPSS Inc, Chicago, Illinois).
Results
The characteristics of the 289 patients included in the study according to race are summarized in Table 1 . The majority of the participants were male. Among the non-African American group, there were 144 Caucasian, 2 Hispanic, and 1 Native American patients. African Americans individuals had significantly higher serum HCV levels than the remaining participants. This might be explained by higher HCV loads among the US patients (median [Md] 822 870 IU/mL [interquartile range, IQR, 260 000-2 607 945 IU/mL) compared to the Italians (Md 680 000 IU/mL [IQR 361 750-1 075 000 IU/ mL]; P < .0001). However, the proportion of patients with HCV RNA levels ! 500 000 IU/mL was similar for African American and non-African American participants. Hepatitis C viral genotype distribution also differed by race, with significantly greater representation of HCV genotype 1 and smaller of genotypes 3 and 4 among African Americans compared to the others. Although AST levels were comparable among races, African Americans had significantly lower ALT levels than the remaining patients.
Alanine aminotransferase levels were higher among patients with HCV RNA levels >500 000 IU/mL (Md 58 [IQR 38-89]) compared to those with HCV RNA < 500 000 IU/mL (Md 43 [IQR 28-66]; P < .0001). There was no association between higher HCV RNA levels and sex, race, HCV genotype, or study center. There was correlation between ALT and HCV RNA levels among patients with HCV genotype 3 (R ¼ .5; P ¼ .002), but not with other genotypes.
There were also differences in ALT levels across HCV genotypes. Thus, media ALT levels were 60 IU/L for patients with HCV-1, 81 IU/L with HCV-2, 103 IU/L with HCV-3, and 76 IU/L with HCV-4 (P < .0001). The results of linear regression analyses searching for factors associated with ALT levels are shown in Table 2 . In multivariate analysis, only HCV genotype 3 and HCV RNA >500 000 IU/mL were independent predictors of higher ALT levels. Per AASLD definition, 18.2% had ALT levels within normal limits, with a trend among African-American patients to fall into that category (Table 1 ). There was a significantly higher proportion of males with ALT within normal limits (46/211 [21.8%]) than of females (6/75 [8%]; P ¼ .01). In like manner, ALT within normal limits were more frequent among patients with HCV RNA <500 000 IU/mL (26/100 [26%]) than among those with !500 000 IU/mL (26/186 [14%]; P ¼ .01). In multivariate logistic regression analysis, both male sex and lower HCV RNA levels predicted having within normal limits ALT (Table 3 ).
Discussion
Assessment of the liver tissue status is crucial for the management of chronic HCV infection. Hepatic biopsy being the only way to directly visualize the degree of inflammation and fibrosis present in the liver, noninvasive tools to ''predict'' liver damage are being very actively researched. Although there is not a perfect correlation between the levels of transaminases and the degree of liver damage, to some extent ALT levels can give an idea of the impact of the HCV on the liver. Thus, elevated ALT correlates with liver inflammatory activity, necrosis, and fibrosis. 3,6,10-13 Elevated ALT levels have also been shown to be associated with liver disease progression to cirrhosis compared to patients with low transaminase values. [13] [14] [15] [16] Being an inexpensive and easy-to-obtain parameter, ALT levels are a very useful tool in the monitoring of the course of HCV infection.
Which are the determinant factors of ALT levels? Being the result of hepatocyte injury and lysis, ALT levels will increase as a result of the inflammation elicited in the liver by the HCV viral particles. However, the ultimate factors that determine the immunologic and inflammatory response to the HCV are not well known at this time. Among host factors, female sex has been associated with lower ALT levels, and several studies also report lower ALT levels in African Americans compared to Caucasians. [4] [5] [6] [7] 17, 18 In the current study, which analyzes HIV/HCV-coinfected patients, ALT levels were lower among African Americans compared to Caucasians. However, viral factors were identified as more important predictors of ALT levels according to our results. Thus, serum HCV RNA !500 000 IU/mL and HCV genotype 3 were both independent factors associated with higher ALT levels, while the racial differences lost their statistical significance in the multivariate analysis.
Prior studies had also shown that HIV/HCV-coinfected patients with genotype 3 have higher ALT levels compared to other HCV genotypes. 19, 20 Interestingly, those differences in ALT across genotypes have not been reported for HCVmonoinfected patients. 10 It is unclear why among HIV-infected patients with HCV coinfection, different genotypes should determine distinct levels of transaminases. It is unknown whether the immune suppression induced by the HIV could determine higher degrees of liver inflammation and therefore of ALT levels with HCV genotype 3. Additional studies are needed to confirm our finding and to explore the underlying reasons. ----African American À21.19 (À34.52 to À7.86); .002 À11.32 (À26.9 to 4.26); .1 CD4 counts À.007 (À.032 to .019); .6 ----On antiretroviral treatment À15.51 (À29.61 to À1.41); .03 À3.95 (À19.72 to 11.82); .6 HCV RNA ! 5 Â 10 5 IU/mL 22.50 (8.53 to 36.48); .002 21.27 (7.71 to 34.83); .002 HCV genotype 1 versus others À26.82 (À41.32 to À12.32); <.0001 ----HCV genotype 3 versus others 40.94 (22.39 to 59.49); <.0001 32.46 (12.90 to 52.02); .001
Abbreviations: ALT, alanine aminotransferase; HCV, hepatitis C. a. Univariate and multivariate linear regression analyses. Our data also support previous findings of higher levels of HCV replication among patients with higher transaminase levels. [11] [12] [13] [21] [22] [23] [24] [25] To our knowledge, this is the first report among HIV/HCV-coinfected patients. Moreover, in our cohort, among patients with HCV genotype 3, there was correlation between HCV RNA and ALT levels. However, other studies performed in HCV-monoinfected participants have not shown an association between ALT levels and HCV viral load. 3, 18, [26] [27] [28] Although within our HIV/HCV-coinfected population, African Americans also had lower ALT levels than Caucasians in the univariate analysis, other factors accounted for the differences when viral factors were included in the analyses. These findings contradict previous observations in HCV-infected patients. It is unclear whether the disparity has its origin on the HIV coinfection or whether additional nonaccounted factors are responsible for the differences. In like manner, our results do not support previous findings of lower ALT levels among females compared to males in HCV-infected and HIV/HCV-coinfected patients. 17, 18, 29 Therefore, viral rather than host factors seem to be associated with ALT levels among HIV/HCV-coinfected patients.
These results may be hindered by the limitations of retrospective analyses. Other weaknesses of our study are the lack of information on alcohol use, antiretroviral therapy, and concomitant medications, factors that might affect transaminase levels. Counterbalancing these weaknesses, the study is based on a large and diverse population, with minimal selection bias because the data result from standard assessment regardless of indication for HCV treatment.
The clinical implications of our results rely on the liver damage that is associated with ALT levels. Less liver inflammatory activity and less advanced fibrosis have been shown among HCV-monoinfected patients with low ALT values. 3, [10] [11] [12] [13] [14] [15] [16] And that is true as well for African Americans infected by HCV, who have not only lower ALT levels but also less liver damage than Caucasians. 4, 6, 7 The positive correlation between liver inflammation/fibrosis and ALT values has also been shown to hold true for HIV/HCV-coinfected patients. 20, 29, 30 However, our results suggest that HIV/HCV-coinfected African Americans may not have milder liver disease than Caucasians and that HCV replication activity could be a more important factor driving ALT levels and liver inflammation. Nevertheless, we do not have histological data to prove this. Further studies are needed to better understand the interactions between the host and the HCV as well as the effect on liver damage.
In summary, HCV factors rather than race were associated with ALT levels in this HIV/HCV-coinfected population. Thus, patients with genotype HCV-3 and RNA >500 000 IU/mL had higher ALT levels. Alanine aminotransferase were within normal limits in 18% of patients, more often among males and those with HCV RNA <500 000 IU/L. Our results suggest that HIV/HCV-coinfected African Americans may not have milder liver disease than Caucasians and that HCV levels of replication could be a more important factor driving ALT levels and liver inflammation activity.
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